AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Total Assets (Quarterly): 104.34B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 104.34B |
| March 31, 2024 | 102.29B |
| December 31, 2023 | 101.12B |
| September 30, 2023 | 96.09B |
| June 30, 2023 | 96.54B |
| March 31, 2023 | 96.69B |
| December 31, 2022 | 96.48B |
| September 30, 2022 | 94.18B |
| June 30, 2022 | 96.58B |
| March 31, 2022 | 100.27B |
| December 31, 2021 | 105.36B |
| September 30, 2021 | 107.22B |
| June 30, 2021 | 73.64B |
| March 31, 2021 | 64.93B |
| December 31, 2020 | 66.73B |
| September 30, 2020 | 64.11B |
| June 30, 2020 | 59.93B |
| March 31, 2020 | 57.21B |
| December 31, 2019 | 61.38B |
| September 30, 2019 | 58.91B |
| June 30, 2019 | 61.89B |
| March 31, 2019 | 61.06B |
| December 31, 2018 | 60.65B |
| September 30, 2018 | 61.44B |
| June 30, 2018 | 61.34B |
| Date | Value |
|---|---|
| March 31, 2018 | 63.28B |
| December 31, 2017 | 63.35B |
| September 30, 2017 | 64.59B |
| June 30, 2017 | 65.12B |
| March 31, 2017 | 60.96B |
| December 31, 2016 | 62.53B |
| September 30, 2016 | 63.22B |
| June 30, 2016 | 64.42B |
| March 31, 2016 | 64.32B |
| December 31, 2015 | 60.06B |
| September 30, 2015 | 54.12B |
| June 30, 2015 | 55.17B |
| March 31, 2015 | 53.70B |
| December 31, 2014 | 58.60B |
| September 30, 2014 | 56.16B |
| June 30, 2014 | 58.54B |
| March 31, 2014 | 59.39B |
| December 31, 2013 | 55.90B |
| September 30, 2013 | 54.12B |
| June 30, 2013 | 53.99B |
| March 31, 2013 | 52.33B |
| December 31, 2012 | 53.53B |
| September 30, 2012 | 52.45B |
| June 30, 2012 | 51.39B |
| March 31, 2012 | 50.76B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
57.21B
Minimum
Mar 2020
107.22B
Maximum
Sep 2021
86.58B
Average
96.48B
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 321.70M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
| NuCana PLC | 25.38M |
| Autolus Therapeutics PLC | 853.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 64.74B |
| Shareholders Equity (Quarterly) | 39.51B |
| Debt to Equity Ratio | 0.8173 |
| Current Ratio | 0.8889 |
| Net Debt Paydown Yield | -0.14% |